Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo

BMC Immunology

Volumn 10, Issue , 2009, Pages

  Bonville, Cynthia A ^a   Percopo, Caroline M ^b   Dyer, Kimberly D ^b   Gao, Jiliang ^b   Prussin, Calman ^b   Foster, Barbara ^b,c   Rosenberg, Helene F ^b   Domachowske, Joseph B ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Proteus Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA RECEPTOR; UNCLASSIFIED DRUG; INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EX VIVO STUDY; GENE DELETION; GENE OVEREXPRESSION; IN VIVO STUDY; LUNG EDEMA; MOUSE; MURINE PNEUMONIA VIRUS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL MOTION; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL; NEUTROPHIL; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIROLOGY; VIRUS INFECTION;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL3; GENE EXPRESSION PROFILING; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MURINE PNEUMONIA VIRUS; NEUTROPHILS; PNEUMOVIRUS INFECTIONS; PULMONARY EDEMA; RECEPTORS, CCR1; RECEPTORS, INTERFERON; RESPIRATORY INSUFFICIENCY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 63849188693     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-14     Document Type: Article

References (57)

1. Bauer TT Ewig S Rodloff AC Müller E Acute respiratory distress syndrome and pneumonia: A comprehensive review of clinical data Clin Infect Dis 2006, 43:748-756. 10.1086/506430 16912951
2. Hammer J Numa A Newth CJ Acute respiratory distress syndrome caused by respiratory syncytial virus Pediatr Pulmonol 1997, 23:176-183. 10.1002/ (SICI)1099-0496(199703)23:3<176::AID-PPUL2>3.0.CO;2-M 9094725
3. Xu T Qiao J Zhao L Wang G He G Li K Tian Y Gao M Wang J Wang H Dong C Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice Am J Respir Crit Care Med 2006, 174:1011-1017. 10.1164/ rccm.200511-1751OC 16917113
4. Chen CY Lee CH Liu CY Wang JH Wang LM Perng RP Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome J Chin Med Assoc 2005, 68:4-10. 15742856
5. Salto-Tellez M Tan E Lim B ARDS in SARS: Cytokine mediators and treatment implications Cytokine 2005, 29:92-94. 10.1016/ j.cyto.2004.09.002 15598444
6. Ginsburg HS Horsfall FL Jr Characteristics of the multiplication cycle of pneumonia virus of mice (PVM) J Exp Med 1951, 93:151-160. 2136057 14803639 10.1084/jem.93.2.151
7. Rosenberg HF Bonville CA Easton AJ Domachowske JB The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention Pharmacol Ther 2005, 105:1-6. 10.1016/j.pharmthera.2004.09.001 15626452
8. Easton AJ Domachowske JB Rosenberg HF Pneumonia virus of mice Perspectives in Medical Virology Cane P 2006, 12:299-319. 10.1016/ S0168-7069(06)14010-0
9. Rosenberg HF Domachowske JB Pneumonia virus of mice: Severe respiratory infection in a natural host Immunol Lett 2008, 118:6-12. 10.1016/ j.imlet.2008.03.013 18471897
10. Bennett NJ Ellis JA Bonville CA Rosenberg HF Domachowske JB Immunization strategies for the prevention of pneumovirus infections Expert Rev Vaccines 2007, 6:169-182. 10.1586/14760584.6.2.169 17408367
11. Thomas LH Friedland JS Sharland M Chemokines and their receptors in respiratory disease: A therapeutic target for respiratory syncytial virus infection Expert Rev Anti Infect Ther 2007, 5:415-425. 10.1586/ 14787210.5.3.415 17547506
12. Bonville CA Bennett NJ Koehnlein M Haines DM Ellis JA DelVecchio AM Rosenberg HF Domachowske JB Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis Virology 2006, 349:87-95. 10.1016/j.virol.2006.02.017 16563455
13. Domachowske JB Bonville CA Gao JL Murphy PM Easton AJ Rosenberg HF The chemokine macrophage-inflammatory protein-1alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection J Immunol 2000, 165:2677-2682. 10946298
14. Bonville CA Easton AJ Rosenberg HF Domachowske JB Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents J Virol 2003, 77:1237-1244. 140832 12502841 10.1128/JVI.77.2.1237-1244.2003
15. Bonville CA Lau VK DeLeon JM Gao JL Easton AJ Rosenberg HF Domachowske JB Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo J Virol 2004, 78:7984-7989. 446089 15254170 10.1128/JVI.78.15.7984-7989.2004
16. Wheelock EF Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin Science 1965, 149:310-311. 10.1126/ science.149.3681.310
17. Pitrez PM Brennan CS Sly PD Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections Respirology 2005, 10:365-370. 10.1111/j.1440-1843.2005.00721.x 15955151
18. Melendi GA Laham FR Monsalvo AC Casellas JM Israelí V Polack NR Kleeberger SR Polack FP Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants Pediatrics 2007, 120:e410-e415. 10.1542/peds.2006-3283 17671045
19. Semple MG Dankert HM Ebrahimi B Correia JB Booth JA Stewart JP Smyth RL Hart GA Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P PLoS ONE 2007, 2:e1038. 2001182 17940602 10.1371/journal.pone.0001038
20. Renzi PM Turgeon JP Marcotte JE Drblik SP Berube D Gagnon MF Spier S Reduced interferon-gamma production in infants with bronchiolitis and asthma Am J Respir Crit Care Med 1999, 159:1417-1422. 10228104
21. Aberle JH Aberle SW Dworzak MN Mandl SW Rebhandl W Vollnhofer G Kundi M Popow-Kraupp T Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease Am J Respir Crit Care Med 1999, 160:1263-1268. 10508817
22. Bont L Heijnen CJ Kavelaars A van Aalderen WM Brus F Draaisma JM Pekelharing-Berghuis M van Diemen-Steenvoorde RA Kimpen JL Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity J Infect Dis 2001, 184:355-358. 10.1086/322035 11443563
23. Legg JP Hussain IR Warner JA Johnston SL Warner JO Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis Am J Respir Crit Care Med 2003, 168:633-639. 10.1164/rccm.200210-1148OC 12773328
24. Lee FE Walsh EE Falsey AR Lumb ME Okam NV Liu N Divekar AA Hall CB Mossmann TR Human infant respiratory syncytial virus (RSV) - specific type 1 and 2 cytokine responses ex vivo during primary RSV infection J Infect Dis 2007, 195:1779-1788. 10.1086/518249 17492594
25. Lee YM Miyahara N Takeda K Prpich J Oh A Balhorn A Joetham A Gelfand EW Dakhama A IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus Am J Respir Crit Care Med 2008, 177:208-218. 2204078 17962634 10.1164/rccm.200612-1890OC
26. Mejías A Chávez-Bueno S Ríos AM Saavedra-Lozano J Fonseca Aten M Hatfield J Kapur P Gómez AM Jafri HS Ramilo O Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model Antimicrob Agents Chemother 2004, 48:1811-1822. 400529 15105140 10.1128/AAC.48.5.1811-1822.2004
27. Durbin JE Durbin RK Respiratory syncytial virus-induced immunoprotection and immunopathology Viral Immunol 2004, 17:370-380. 10.1089/ vim.2004.17.370 15357903
28. Johnson TR Mertz SE Gitiban N Hammond S Legallo R Durbin RK Durbin JE Role for innate IFNs in determining respiratory syncytial virus immunopathology J Immunol 2005, 174:7234-7241. 15905569
29. Claassen EA Kant van der PA Rychnavska ZS van Bleek GM Easton AJ Most van der RG Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection J Immunol 2005, 175:6597-6604. 16272314
30. Frey S Krempl CD Schmitt-Graf A Ehl S The role of T cells in virus control and disease after infection with pneumonia virus of mice J Virol 2008, 82:11619-11627. 10.1128/JVI.00375-08 18815308
31. Cook DN Beck MA Coffman TM Kirby SL Sheridan JF Pragnell IB Smithies O Requirement of MIP-1 alpha for an inflammatory response to viral infection Science 1995, 269:1583-1585. 10.1126/science.7667639 7667639
32. Olszewski MA Huffnagle GB McDonald RA Lindell DM Moore BB Cook DN Toews GB The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection J Immunol 2000, 165:6429-6436. 11086082
33. Nys M Deby-Dupont G Habraken Y Legrand-Poels S Kohnen S Ledoux D Canivet JL Damas P Lamy Y Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: Role of reactive oxygen/nitrogen species and cytokines Nitric Oxide 2003, 9:33-43. 10.1016/j.niox.2003.07.001 14559430
34. Yang KY Arcaroli JJ Abraham E Early alterations in neutrophil activation are associated with outcome in acute lung injury Am J Respir Crit Care Med 2003, 167:1567-1574. 10.1164/rccm.200207-664OC 12626346
35. Arcaroli J Yang KY Yum HK Kupfner J Pitts TM Park JS Strassheim D Abraham E Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia J Leukoc Biol 2002, 72:571-579. 12223526
36. Geerts L Jorens PG Willems J De Ley M Slegers H Natural inhibitors of neutrophil function in acute respiratory distress syndrome Crit Care Med 2001, 29:1920-1924. 10.1097/00003246-200110000-00012 11588452
37. Johnson JL Moore EE Tamura DY Zallen G Biffl WL Silliman CC Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release J Surg Res 1998, 76:91-94. 10.1006/ jsre.1998.5295 9695746
38. He M Horuk R Bhatia M Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modifying neutrophil recruitment Pancreas 2007, 34:233-241. 10.1097/mpa.0b013e31802e7598 17312463
39. Anh DB Faisca P Desmecht DJ Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains Am J Physiol Lung Cell Mol Physiol 2006, 291:L426-L435. 10.1152/ ajplung.00483.2005 16556725
40. McNamara PS Flanagan BF Hart CA Smyth RL Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis J Infect Dis 2005, 191:1225-1232. 10.1086/428855 15776367
41. Harrison AM Bonville CA Rosenberg HF Domachowske JB Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation Am J Respir Crit Care Med 1999, 159:1918-1924. 10351940
42. Huang KJ Su IJ Theron M Wu YC Lai SK Liu CC Lei HY An interferon-gamma related cytokine storm in SARS patients J Med Virol 2005, 75:185-194. 10.1002/jmv.20255 15602737
43. Glass WG Subbarao K Murphy B Murphy PM Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice J Immunol 2004, 173:4030-4039. 15356152
44. Yen YT Liao F Hsiao CH Kao CL Chen YC Wu-Hsieh BA Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro J Virol 2006, 80:2684-2693. 1395447 16501078 10.1128/ JVI.80.6.2684-2693.2006
45. To KF Chan PKS Chan KF Lee WK Lam WY Wong KF Tang NLS Tsang DNC Sung RYT Buckley TA Tam JS Cheng AF Pathology of fatal human infection associated with avian influenza A H5N1 virus J Med Virol 2001, 63:242-246. 10.1002/ 1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N 11170064
46. Szretter KJ Gangappa S Lu X Smith C Wun-Ju S Zaki SR Sambhara S Tumpey TM Katz JM Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice J Virol 2007, 81:2736-2744. 1866007 17182684 10.1128/JVI.02336-06
47. Zhou J Law HKW Cheung CY Ng IHY Peiris JSM Lau YL Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses J Infect Dis 2006, 194:61-70. 10.1086/504690 16741883
48. Gao JL Wynn TA Chang Y Lee EJ Broxmeyer HE Cooper S Tiffany HL Westphal H Kwon-Chung J Murphy PM Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 J Exp Med 1997, 185:1959-1968. 2196337 9166425 10.1084/jem.185.11.1959
49. Ellis TN Beaman BL Interferon-γ activation of polymorphonuclear neutrophil function Immunology 2004, 112:2-12. 1782470 15096178 10.1111/ j.1365-2567.2004.01849.x
50. Hansen BD Finbloom DS Characterization of the interaction between recombinant human interferon-γ and its receptor on human polymorphonuclear leukocytes J Leukoc Biol 1990, 47:64-69. 2136748
51. Bonecchi R Polentarutti N Luini W Borsatti A Bernasconi S Locati M Power C Proudfoot A Wells TN Mackay C Mantovani A Sozzani S Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-g in human neutrophils J Immunol 1999, 162:474-479. 9886422
52. Khader SA Partida-Sanchez S Bell G Jelley-Gibbs DM Swain S Pearl JE Ghilardi N Desauvage FJ Lund FE Cooper AM Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection J Exp Med 2006, 203:1805-1815. 2118335 16818672 10.1084/jem.20052545
53. Dalton DK Pitts-Meek S Keshav S Figari IS Bradley A Stewart TA Multiple defects of immune cell function in mice with disrupted interferon-gamma genes Science 1993, 259:1739-1742. 10.1126/science.8456300 8456300
54. Huang S Hendriks W Althage A Hemmi S Bluethmann H Kamijo R Vilcek J Zinkernagel RM Aguet M Immune response in mice that lack the interferon-gamma receptor Science 1993, 259:1742-1745. 10.1126/ science.8456301 8456301
55. Foster B Prussin C Unit 6.24, Detection of intracellular cytokines by flow cytometry Current Protocols in Immunology Wiley Coligan JE, Kruisbeek AM, Marguilies DH, Shevach EM, Strober W 2003:6.24.1-6.24.16.
56. Gao JL Guillabert A Hu J Le Y Urizar E Seligman E Fang KJ Yuan X Imbault V Communi D Wang JM Parmentier M Murphy PM Migeotte I F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor J Immunol 2007, 178:1450-1456. 17237393
57. Ellis JA Martin BV Waldner C Dyer KD Domachowske JB Rosenberg HF Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice Vaccine 2007, 25:1085-1095. 1922442 17052820 10.1016/ j.vaccine.2006.09.081